v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Sales, net of returns and allowances $ 6,137 $ 9,573 $ 14,028 $ 11,469
Cost of sales 15,697 10,970 38,542 15,304
Gross loss (9,560) (1,397) (24,514) (3,835)
Operating expenses:        
Selling, general and administrative 7,368 5,062 24,753 13,871
Research and development 3,749 2,793 11,926 9,650
Total operating expenses 11,117 7,855 36,679 23,521
Loss from operations (20,677) (9,252) (61,193) (27,356)
Interest expense, net (1,379) (5,623) (2,533) (13,018)
Change in fair value of convertible note 338 0 61 0
Change in fair value of stock rights 0 0 1,885 0
Other expense (70) 1 (95) (3)
Loss before benefit for income taxes (21,788) (14,874) (61,875) (40,377)
Benefit for income taxes 0 0 34 0
Net loss $ (21,788) $ (14,874) $ (61,841) $ (40,377)
Net loss per share of common stock - basic (in dollars per share) $ (2.00) $ (1.55) $ (5.84) $ (4.29)
Net loss per share of common stock - diluted (in dollars per share) $ (2.00) $ (1.55) $ (5.84) $ (4.29)
Weighted-average shares used in computing net loss per share of common stock - basic (in shares) 10,915 9,599 10,598 9,421
Weighted-average shares used in computing net loss per share of common stock - diluted (in shares) 10,915 9,599 10,598 9,421

Source